Chronic pain clinical trials in Penticton, British Columbia
3
Trials
0
Recruiting or not yet
3
Trial sites
Trials with a site in Penticton
3 trials, recruiting first
| Phase | ||||
|---|---|---|---|---|
| A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain NCT00973141 | Terminated | Phase 2 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2009-09-16 |
| A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Low Back Pain NCT00973024 | Terminated | Phase 2 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2009-09 |
| An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain NCT00487435 | Completed | Phase 3 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2007-06 |
Map
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.